Molecular Stethoscope
The startup develops a molecular diagnostics technology that analyzes tissue-specific cell-free circulating ribonucleic acid in blood samples to monitor organ damage. This early detection method provides physicians with critical genetic information to differentiate between healthy and disease states in patients.
- Biotechnology
Updated 21 months ago
Funding
Raised to date
$19.2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a molecular diagnostics technology that analyzes tissue-specific cell-free circulating ribonucleic acid in blood samples to monitor organ damage. This early detection method provides physicians with critical genetic information to differentiate between healthy and disease states in patients.